|
|
|
|
Use of radiation therapy for patients with soft-tissue and bone sarcomas
_ Use of radiation therapy for patients with soft-tissue and bone sarcomas.
|
|
|
Vail race will raise money for boy battling cancer
Donations at Vail race may be designated to the Thomas Walsh Medical Trust Vail Daily staff report Vail, CO Colorado Share on FacebookEmail Print Comment VAIL Alpine Children's Charity will hold its sixth annual Cruisin' for Kids ski-a-thon on March 26 on Vail...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Yondelis(R) has been approved for soft tissue sarcoma (STS) in Israel, Panama and Ukraine.Additionally, the authorities in Paraguay and Azerbaijan have approved the drug for platinum-sensitive recurrent ovarian cancer (ROC). Yondelis(R) is...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
MADRID The European Commission approved Yondelis(R) for platinum-sensitive ROC in September 2009 In view of the three new approvals for STS, Yondelis(R) now has authorization for this indication in 25 countries outside the EEA: Argentina Clinical trials are...
|
|
|
Update and review of the management of bone tumours
Siller CS et al.Osteosarcoma and Ewing's sarcoma are the commonest of these, usually occurring in the absence of an underlying cause. Peak incidence occurs in adolescence. Patients and families commonly report delays prior to referral for...
|
|
|
Yondelis Receives Five New Approvals Outside the European Economic Area
Yondelis(R) has been approved for soft tissue sarcoma (STS) in Israel, Panama and Ukraine.Additionally, the authorities in Paraguay and Azerbaijan have approved the drug for platinum-sensitive recurrent ovarian cancer (ROC). Yondelis(R) is...
|
|
|
ARIAD Reports Development Progress and Fourth Quarter and Year-End 2009 Financial Results
Phase 3 Sarcoma Data in 2010 ARIAD expects to have results this year from the Phase 3 SUCCEED trial of oral ridaforolimus -- its investigational mTOR inhibitor -- in patients with metastatic soft tissue and bone sarcomas, who have had a...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
|
|
Yondelis(R) Receives Five New Approvals Outside the European Economic Area
Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.Furthermore, the authorities in...
|
